|
PTPN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.210770E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.195600E-01 |
| Normal-vs-Stage2 |
4.254600E-01 |
| Normal-vs-Stage3 |
4.305600E-01 |
| Normal-vs-Stage4 |
4.443800E-01 |
| Stage1-vs-Stage2 |
7.996400E-01 |
| Stage1-vs-Stage3 |
7.396000E-01 |
| Stage1-vs-Stage4 |
5.589600E-01 |
| Stage2-vs-Stage3 |
9.693000E-01 |
| Stage2-vs-Stage4 |
6.305200E-01 |
| Stage3-vs-Stage4 |
6.452000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.769780E-01 |
| Normal-vs-AfricanAmerican |
2.861400E-01 |
| Normal-vs-Asian |
1.270450E-01 |
| Caucasian-vs-AfricanAmerican |
9.465600E-01 |
| Caucasian-vs-Asian |
5.296200E-01 |
| AfricanAmerican-vs-Asian |
4.305000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.746000E-01 |
| Normal-vs-Female |
3.316100E-02 |
| Male-vs-Female |
8.098400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.094400E-01 |
| Normal-vs-Extreme_Weight |
5.554200E-01 |
| Normal-vs-Obese |
3.822600E-01 |
| Normal-vs-Extreme_Obese |
6.722200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.705000E-01 |
| Normal_Weight-vs-Obese |
5.375000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.007200E-01 |
| Extreme_Weight-vs-Obese |
7.060400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.224600E-01 |
| Obese-vs-Extreme_Obese |
3.206800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.089500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.082010E-01 |
| Normal-vs-Age(61-80Yrs) |
3.236800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.768000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.603600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.013010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.593670E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.791200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.269500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.255800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.968010E-01 |
| Normal-VS-Type2 PRCC |
7.864000E-01 |
| Normal-VS-KIRP CIMP |
1.841750E-03 |
| Normal-VS-Unclassified PRCC |
3.029400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.959800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.117800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.913000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.163600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.972050E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.097190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.351400E-01 |
| Normal-vs-N1 |
1.129770E-02 |
| Normal-vs-N2 |
9.979800E-01 |
| N0-vs-N1 |
1.124100E-02 |
| N0-vs-N2 |
9.736600E-01 |
| N1-vs-N2 |
1.974420E-02 |
|
|
